SCHEMBL15782873

SCHEMBL15782873

CCc1cc2cccc(O)c2c(O)c1C(C)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.50
DNMT1 P26358 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
MCL1 Q07820 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
THRB P10828 2/20 0.47
PRKCI P41743 1/20 0.44
MAOA P21397 2/20 0.41
MAOB P27338 1/20 0.41
EP300 Q09472 1/20 0.40
CREBBP Q92793 1/20 0.40
BRD9 Q9H8M2 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12948360 0.94 MEN1 (0.53) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL12800165 0.89 MEN1 (0.49) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL24079188 0.87 PRKCI (0.46) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL15782863 0.82 MAPT (0.45) MEN1KMT2AGAAMAPTCYP3A4
Nepodin SCHEMBL1673268 0.81 MEN1 (0.53) MEN1ALDH1A1KMT2ADNMT1CACNA1B
Nepodin SCHEMBL30189621 0.81 MEN1 (0.53) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL16433056 0.81 MEN1 (0.46) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL15782864 0.79 MEN1 (0.48) MEN1KMT2APRKCIMAPTKDM4E
SCHEMBL18598736 0.78 MEN1 (0.34) MEN1ALDH1A1KMT2ADNMT1CACNA1B
SCHEMBL15782860 0.78 CA12 (0.44) MEN1ALDH1A1KMT2AMCL1PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488152-B1 COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION OREAL (FR) 2018-04-04 EP disclosed
US-9884830-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-02-06 US disclosed
EP-1753713-B1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF HARVARD COLLEGE (US) 2016-07-27 EP disclosed
US-9365493-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-06-14 US disclosed
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC MEN1 1643/4885ALDH1A1 4455/4885KMT2A 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.